Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 1.000 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.658 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.653 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.648 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.628 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.608 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.608 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.606 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.603 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.603 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.597 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.590 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.584 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.571 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.568 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.566 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.559 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.549 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.548 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.541 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.541 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.537 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.535 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.533 | |
| 4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.527 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.523 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.516 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.515 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.507 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.505 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.502 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.498 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.497 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.496 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.496 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.496 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.495 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.494 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.492 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.490 | |
| 3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.486 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.485 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.484 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.483 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.483 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.482 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.482 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.482 | |
| 4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.482 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.480 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.480 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.479 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.479 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.478 | |
| 3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.477 | |
| 3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.476 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.476 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.475 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.473 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.473 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.473 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
| 3t2y | FAD | Sulfide-quinone reductase | / | 0.471 | |
| 3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.470 | |
| 4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.469 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.468 | |
| 3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.468 | |
| 3ogq | AB1 | Pol polyprotein | / | 0.467 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.467 | |
| 3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.466 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.466 | |
| 1idb | 0DO | Gag-Pol polyprotein | / | 0.465 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.465 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.464 | |
| 3icr | COA | Coenzyme A disulfide reductase | / | 0.464 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.464 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.463 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.463 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.463 | |
| 1osv | CHC | Bile acid receptor | / | 0.462 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.462 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.462 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 1mes | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.461 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.461 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.461 | |
| 3w8w | FAD | Putative FAD-dependent oxygenase EncM | / | 0.461 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.461 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.461 | |
| 1zmd | NAI | Dihydrolipoyl dehydrogenase, mitochondrial | 1.8.1.4 | 0.460 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
| 2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.459 | |
| 2y01 | Y01 | Beta-1 adrenergic receptor | / | 0.459 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.459 | |
| 3iw8 | HIZ | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.459 | |
| 4z35 | ON9 | Lysophosphatidic acid receptor 1 | / | 0.459 | |
| 1bve | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.458 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.458 | |
| 3b70 | NAP | Enoyl reductase LovC | 1 | 0.458 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.457 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.457 | |
| 3w2c | N15 | Aurora kinase A | 2.7.11.1 | 0.457 | |
| 4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.457 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.456 | |
| 3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.456 | |
| 3q71 | AR6 | Poly [ADP-ribose] polymerase 14 | 2.4.2.30 | 0.456 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.456 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.456 | |
| 4l2i | FAD | Electron transfer flavoprotein alpha/beta-subunit | / | 0.456 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.456 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.455 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.455 | |
| 3gw9 | VNI | Lanosterol 14-alpha-demethylase | / | 0.455 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.455 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.455 | |
| 2nu9 | COA | Succinate--CoA ligase [ADP-forming] subunit alpha | 6.2.1.5 | 0.454 | |
| 2yaa | ATP | Death-associated protein kinase 2 | / | 0.454 | |
| 4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.454 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.454 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
| 4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.454 | |
| 1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.453 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.453 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.453 | |
| 1bvg | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.452 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.452 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.452 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.452 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.452 | |
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.451 | |
| 2azz | TCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.451 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.450 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 4a6b | QG8 | Gag-Pol polyprotein | 3.4.23.16 | 0.450 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.449 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.449 | |
| 4aw3 | MYV | Mycinamicin IV hydroxylase/epoxidase | / | 0.449 | |
| 4k2x | FAD | Polyketide oxygenase/hydroxylase | / | 0.449 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.449 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
| 2y03 | Y01 | Beta-1 adrenergic receptor | / | 0.448 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.448 | |
| 3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 4mxa | BK7 | Calmodulin-like domain protein kinase isoenzyme gamma, related | / | 0.448 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.448 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.448 | |
| 1kzu | RG1 | Light-harvesting protein B-800/850 alpha chain | / | 0.447 | |
| 1kzu | RG1 | Light-harvesting protein B-800/850 beta chain | / | 0.447 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.447 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.447 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.447 | |
| 1qbs | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
| 2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
| 3b6z | CO7 | Enoyl reductase LovC | 1 | 0.446 | |
| 3h0a | D30 | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.446 | |
| 1c6y | MK1 | Protease | / | 0.445 | |
| 1iid | NHM | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.445 | |
| 1zem | NAD | Xylitol dehydrogenase | / | 0.445 | |
| 2hfp | NSI | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.445 | |
| 3sgx | 0FW | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.445 | |
| 3zdi | UGJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.445 | |
| 4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
| 1meu | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
| 1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.444 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 | |
| 3ics | COA | Coenzyme A disulfide reductase | / | 0.444 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.444 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.444 | |
| 4hee | 14R | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
| 4ih8 | B43 | Calmodulin-domain protein kinase 1 | / | 0.444 | |
| 4wa9 | AXI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.444 | |
| 1kk4 | ACO | Streptogramin A acetyltransferase | 2.3.1 | 0.443 | |
| 1udy | FAD | Medium-chain specific acyl-CoA dehydrogenase, mitochondrial | 1.3.8.7 | 0.443 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.443 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
| 2y02 | Y01 | Beta-1 adrenergic receptor | / | 0.443 | |
| 2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.443 | |
| 3n7u | NAD | Formate dehydrogenase, chloroplastic/mitochondrial | / | 0.443 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.443 | |
| 4j5j | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.443 | |
| 1ppj | SMA | Cytochrome b | / | 0.442 | |
| 1zmc | NAD | Dihydrolipoyl dehydrogenase, mitochondrial | 1.8.1.4 | 0.442 | |
| 2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.442 | |
| 3mg3 | ECH | Orange carotenoid-binding protein | / | 0.442 | |
| 3mwu | BK3 | Calmodulin-domain protein kinase 1, putative | / | 0.442 | |
| 3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 3t2k | FAD | Sulfide-quinone reductase | / | 0.442 | |
| 3vt9 | YI4 | Vitamin D3 receptor | / | 0.442 | |
| 1ot7 | IU5 | Bile acid receptor | / | 0.441 | |
| 2aib | ERG | Beta-elicitin cinnamomin | / | 0.441 | |
| 2hwr | DRD | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
| 2jn3 | JN3 | Fatty acid-binding protein, liver | / | 0.441 | |
| 2q61 | SF1 | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.441 | |
| 2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 3sz0 | FAD | Sulfide-quinone reductase | / | 0.441 | |
| 5doz | NDP | JamJ | / | 0.441 | |
| 2vna | NAP | Prostaglandin reductase 2 | 1.3.1.48 | 0.440 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.440 | |
| 3wmx | NAD | NAD dependent epimerase/dehydratase | / | 0.440 | |
| 4jv8 | 1M1 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.440 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.440 | |
| 4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.440 |